Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally

Clinical Trial Summary

The study aims to observe and investigate the efficacy and safety of Anlotinib capsules in patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma in the real world, and to summarize the treatment experience in a broad population.

See also
Status	Clinical Trial	Phase
Completed	`NCT00537095` - Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer	Phase 2
Recruiting	`NCT04139096` - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed	`NCT00754182` - Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision	N/A
Completed	`NCT00094055` - Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer	Phase 2
Completed	`NCT00148213` - Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma	N/A
Recruiting	`NCT06398795` - Dual-port Trans-subclavian Thyroid Endoscopic Surgery	N/A
Recruiting	`NCT01005654` - Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Active, not recruiting	`NCT05579782` - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy	N/A
Completed	`NCT01437254` - To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer	Phase 1
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed	`NCT00984282` - Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer	Phase 3
Completed	`NCT01292044` - The Role of Elastography in the Diagnosis of Thyroid Nodules	N/A
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Active, not recruiting	`NCT02418247` - Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer	Phase 2/Phase 3
Completed	`NCT00467506` - Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma	Phase 2
Completed	`NCT02430714` - Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Recruiting	`NCT04396912` - Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
Enrolling by invitation	`NCT04411290` - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Recruiting	`NCT04410601` - Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT	N/A
Completed	`NCT03469310` - Minimizing Narcotic Analgesics After Endocrine Surgery	Phase 4

NCT number	NCT05994365
Study type	Observational
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact	Ming Gao, PhD
Phone	+ 86 18622221110
Email	gaoming68@aliyun.com
Status	Recruiting
Phase
Start date	August 2023
Completion date	December 2028

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms